Upregulated histamine receptor H3 promotes tumor growth and metastasis in hepatocellular carcinoma

Yu,Deliang; Zhao,Jing; Wang,Yuhong; Hu,Jing; Zhao,Qinchuan; Li,Jibin; Zhu,Jianjun

doi:10.3892/or.2019.7119

Upregulated histamine receptor H3 promotes tumor growth and metastasis in hepatocellular carcinoma

Authors:
- Deliang Yu
- Jing Zhao
- Yuhong Wang
- Jing Hu
- Qinchuan Zhao
- Jibin Li
- Jianjun Zhu
View Affiliations

Affiliations: Department of Digestive Surgery, Xijing Hospital of Digestive Disease, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China, State Key Laboratory of Cancer Biology and Experimental Teaching Center of Basic Medicine, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China, Emergency Department, The 7th Medical Center of the PLA General Hospital, Beijing 100700, P.R. China, Department of Biology, School of Basic Medicine, Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China
Published online on: April 16, 2019 https://doi.org/10.3892/or.2019.7119
Pages: 3347-3354

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Histamine receptor H3 (HRH3) is mainly expressed in the central nervous system, where it is involved in the regulation of the release of various neurotransmitters in the brain. Recent studies have demonstrated that the expression of HRH3 is upregulated in several types of cancer. However, the functional effect of HRH3 on tumor progression remains largely unknown, particularly in hepatocellular carcinoma (HCC). In the present study, the expression of HRH3 in 96 HCC patients was first evaluated, and its clinical significance was analyzed. Subsequently, the functional roles of HRH3 in HCC growth and metastasis were systematically explored in vitro and in vivo using its agonist (imetit) or antagonist (clobenpropit). It was observed that HRH3 was significantly upregulated in HCC tissues, while its expression was significantly associated with recurrence‑free survival and overall survival in HCC patients. Functional experiments also demonstrated that HRH3 upregulation facilitated the growth and metastasis of HCC cells by inducing the formation of lamellipodia. These findings revealed that HRH3 serves an important role in the growth and metastasis of HCC cells, which provides experimental evidence supporting the application of HRH3 as a potential therapeutic target in HCC treatment.

View Figures

View References

1	Singh M and Jadhav HR: Histamine H3 receptor function and ligands: Recent developments. Mini Rev Med Chem. 13:47–57. 2013. View Article : Google Scholar : PubMed/NCBI
2	Coruzzi G, Adami M and Pozzoli C: Role of histamine H4 receptors in the gastrointestinal tract. Front Biosci. 4:226–239. 2012. View Article : Google Scholar
3	Hegyesi H, Darvas Z, László V, Pós Z, Pállinger E, Hirschberg K, Kovács P and Falus A: Retinoic acid enhances histamine content and H1 receptor expression in human neuroblastoma cell line Paju. Anticancer Res. 24:1657–1663. 2004.PubMed/NCBI
4	Kitakaze M: Clinical evidence of the role of histamine in heart failure. J Am Coll Cardiol. 67:1553–1555. 2016. View Article : Google Scholar : PubMed/NCBI
5	de Esch IJ, Thurmond RL, Jongejan A and Leurs R: The histamine H 4 receptor as a new therapeutic target for inflammation. Trends Pharmacol Sci. 26:462–469. 2005.PubMed/NCBI
6	Medina VA and Rivera ES: Histamine receptors and cancer pharmacology. Brit J Pharmacol. 161:755–767. 2010. View Article : Google Scholar
7	Chen Y, Zhen W, Guo T, Zhao Y, Liu A, Rubio JP, Krull D, Richardson JC, Lu H and Wang R: Histamine receptor 3 negatively regulates oligodendrocyte differentiation and remyelination. PLoS One. 12:e1893802017. View Article : Google Scholar
8	Bhowmik M, Khanam R and Vohora D: Histamine H3 receptor antagonists in relation to epilepsy and neurodegeneration: A systemic consideration of recent progress and perspectives. Brit J Pharmacol. 167:1398–1414. 2012. View Article : Google Scholar
9	Yang XD, Ai W, Asfaha S, Bhagat G, Friedman RA, Jin G, Park H, Shykind B, Diacovo TG, Falus A and Wang TC: Histamine deficiency promotes inflammation-associated carcinogenesis through reduced myeloid maturation and accumulation of CD11b⁺Ly6G⁺ immature myeloid cells. Nat Med. 17:87–95. 2011. View Article : Google Scholar : PubMed/NCBI
10	Tanaka T, Kochi T, Shirakami Y, Mori T, Kurata A, Watanabe N, Moriwaki H and Shimizu M: Cimetidine and clobenpropit attenuate inflammation-associated colorectal carcinogenesis in male ICR mice. Cancers. 8(pii): E252016. View Article : Google Scholar : PubMed/NCBI
11	Wong MC, Jiang JY, Goggins WB, Liang M, Fang Y, Fung FD, Leung C, Wang HH, Wong GL, Wong VW, et al: International incidence and mortality trends of liver cancer: A global profile. Sci Rep. 7:458462017. View Article : Google Scholar : PubMed/NCBI
12	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2^−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
13	Huang Q, Lei Z, Cao H, Li J, Lyu Y, Guo X, Zhang J, Ji L, Ren T, An J, et al: Increased mitochondrial fission promotes autophagy and hepatocellular carcinoma cell survival through the ROS-modulated coordinated regulation of the NFKB and TP53 pathways. Autophagy. 12:999–1014. 2016. View Article : Google Scholar : PubMed/NCBI
14	Zhu J, Jin M, Wang J, Zhang H, Wu Y, Li D, Ji X, Yang H, Yin C, Ren T, et al: TNFα induces Ca²⁺ influx to accelerate extrinsic apoptosis in hepatocellular carcinoma cells. J Exp Clin Canc Res. 37:432018. View Article : Google Scholar
15	Medina V, Croci M, Crescenti E, Mohamad N, Sanchez-Jiménez F, Massari N, Nuñez M, Cricco G, Martin G, Bergoc R, et al: The role of histamine in human mammary carcinogenesis: H3 and H4 receptors as potential therapeutic targets for breast cancer treatment. Cancer Biol Ther. 7:28–35. 2008. View Article : Google Scholar : PubMed/NCBI
16	Szabó PM, Wiener Z, Tömböl Z, Kovács A, Pócza P, Horányi J, Kulka J, Riesz P, Tóth M, Patócs A, et al: Differences in the expression of histamine-related genes and proteins in normal human adrenal cortex and adrenocortical tumors. Virchows Arch. 455:133–142. 2009. View Article : Google Scholar : PubMed/NCBI
17	Lin JJ, Zhao TZ, Cai WK, Yang YX, Sun C, Zhang Z, Xu YQ, Chang T and Li ZY: Inhibition of histamine receptor 3 suppresses glioblastoma tumor growth, invasion, and epithelial-to-mesenchymal transition. Oncotarget. 6:17107–17120. 2015.PubMed/NCBI
18	He GH, Lin JJ, Cai WK, Xu WM, Yu ZP, Yin SJ, Zhao CH and Xu GL: Associations of polymorphisms in histidine decarboxylase, histamine N-methyltransferase and histamine receptor H₃ genes with breast cancer. PLoS One. 9:e977282014. View Article : Google Scholar : PubMed/NCBI
19	Tanaka S, Sakaguchi M, Yoneyama H, Usami Y and Harusawa S: Histamine H₃ receptor antagonist OUP-186 attenuates the proliferation of cultured human breast cancer cell lines. Biochem Biophys Res Commun. 480:479–485. 2016. View Article : Google Scholar : PubMed/NCBI
20	Cricco GP, Mohamad NA, Sambuco LA, Genre F, Croci M, Gutiérrez AS, Medina VA, Bergoc RM, Rivera ES and Martín GA: Histamine regulates pancreatic carcinoma cell growth through H₃ and H₄ receptors. Inflamm Res. 57 (Suppl 1):S23–S24. 2008. View Article : Google Scholar : PubMed/NCBI
21	Francis H, Onori P, Gaudio E, Franchitto A, DeMorrow S, Venter J, Kopriva S, Carpino G, Mancinelli R, White M, et al: H3 histamine receptor-mediated activation of protein kinase Calpha inhibits the growth of cholangiocarcinoma in vitro and in vivo. Mol Cancer Res. 7:1704–1713. 2009. View Article : Google Scholar : PubMed/NCBI
22	Francis H, Franchitto A, Ueno Y, Glaser S, DeMorrow S, Venter J, Gaudio E, Alvaro D, Fava G, Marzioni M, et al: H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMP-dependent PKA/ERK1/2/ELK-1 pathway. Lab Invest. 87:473–487. 2007. View Article : Google Scholar : PubMed/NCBI
23	Davenas E, Rouleau A, Morisset S and Arrang JM: Autoregulation of McA-RH7777 hepatoma cell proliferation by histamine H₃ receptors. J Pharmacol Exp Ther. 326:406–413. 2008. View Article : Google Scholar : PubMed/NCBI
24	Kennedy L, Hodges K, Meng F, Alpini G and Francis H: Histamine and histamine receptor regulation of gastrointestinal cancers. Transl Gastrointest Cancer. 1:215–227. 2012.PubMed/NCBI
25	Grandi D, Schunack W and Morini G: Epithelial cell proliferation is promoted by the histamine H₃ receptor agonist (R)-α-methylhistamine throughout the rat gastrointestinal tract. Eur J Pharmacol. 538:141–147. 2006. View Article : Google Scholar : PubMed/NCBI
26	Medina V, Cricco G, Nuñez M, Martín G, Mohamad N, Correa-Fiz F, Sanchez-Jimenez F, Bergoc R and Rivera ES: Histamine-mediated signaling processes in human malignant mammary cells. Cancer Biol Ther. 5:1462–1471. 2006. View Article : Google Scholar : PubMed/NCBI
27	Machesky LM: Lamellipodia and filopodia in metastasis and invasion. Febs Lett. 582:2102–2111. 2008. View Article : Google Scholar : PubMed/NCBI
28	Brown MC, Perrotta JA and Turner CE: Serine and threonine phosphorylation of the paxillin LIM domains regulates paxillin focal adhesion localization and cell adhesion to fibronectin. Mol Biol Cell. 9:1803–1816. 1998. View Article : Google Scholar : PubMed/NCBI
29	Huang C, Jacobson K and Schaller MD: A role for JNK-paxillin signaling in cell migration. Cell Cycle. 3:4–6. 2004. View Article : Google Scholar : PubMed/NCBI
30	Ren T, Zhang H, Wang J, Zhu J, Jin M, Wu Y, Guo X, Ji L, Huang Q, Zhang H, et al: MCU-dependent mitochondrial Ca²⁺ inhibits NAD⁺/SIRT3/SOD2 pathway to promote ROS production and metastasis of HCC cells. Oncogene. 36:5897–5909. 2017. View Article : Google Scholar : PubMed/NCBI